Nobis Nobis Cartel windows 7 home premium activation key 70-290
Blog archief

Annual Meeting Exclusive

In a number of P/P patients, standard treatment plans just don’t seem to work so other evidence-based treatments may be prescribed. IVIg or Rituximab two expensive treatments require approval by a patient’s medical plan. Many insurers choose to deny these

Geplaatst in Issue 56 - Spring 2009

The Challenges in Selecting the Best Treatment for a Blistering Disease

A major problem physicians and patients face when deciding on the treatment of rare diseases such as pemphigus and bullous pemphigoid is deciding on the best course to take. The decision is difficult as it is best made on the

Geplaatst in Issue 56 - Spring 2009

IPPF Website Wins Second Gold Triangle Award

The American Academy of Dermatology has announced that the International Pemphigus and Pemphigoid Foundation is a 2009 recipient of its prestigious Gold Triangle Award given for its patient website, www.pemphigus.org. Will Zrnchik, Director of Communications, accepted the award on behalf

Geplaatst in Issue 56 - Spring 2009

JOIN TODAY!

The P/P Registry has been approved by the Western Institutional Review Board (WIRB) and is actively enrolling participants.

ENGLISH VERSION